Skip to the page

Data / Form D filings / Cardax Pharma, Inc.

Cardax Pharma, Inc.: Form D filings

Cardax Pharma, Inc., a pharmaceuticals company in Honolulu, HI, filed 2 Form D notices with the SEC between 2013 and 2014. The latest, on January 17, 2014, reports $2.1 million sold of a $5 million offering to 26 investors.

Find out what Cardax Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2800 WOODLAWN DRIVE, SUITE 129, Honolulu, HI, 96822
Phone
(808) 457-1399
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2013
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1579166

The full lists. Form D filings in Hawaii: 59 rows, $5, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 17, 2014New notice$5,000,000$2,076,000$2,924,00026Jan 3, 2014sec.gov
Jun 17, 2013New notice$10,000,000$781,170$9,218,8303May 31, 2013sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Nicholas G. MitsakosDirector
David G. WatumullExecutive Officer
Frank C. HerringerDirector

Other pharmaceuticals companies in Hawaii that filed recently

Every Form D from the week of Jan 13, 2014 · All recent filings in Hawaii · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Cardax Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.